The COVID-19 pandemic has drawn light to some key challenges faced by Hispanic communities in the U.S. to access healthcare services. Aiming to offer personalized health services to these communities, digital healthcare platform MiSalud Inc. has recently announced launching its new platform ‘MiSalud’, which translates to "My Health" in Spanish, backed by a latest $5 million funding.
According to the CDC, Hispanics were around three times more likely to be hospitalized and 2.3 times likely to die from Covid-19. In addition, Hispanics are also 24% more likely to have unrestrained hypertension, 23% more likely to be overweight, and 50% more likely to die from diabetes due to long-standing inequities in the healthcare system.
Apart from this, the Hispanic community is also the one who are uninsured and do not have a primary care physician. MiSalud intends to address these gaps by providing culturally relevant medical and wellness services through its mobile app in real-time, in patient's original language.
Wendy Johansson, MiSalud’s Co-Founder and Chief Product Officer, said that MiSalud is a one-of-a-kind combination of individualized preventative wellness services and standard healthcare provided by Spanish-speaking doctors.
As per Wendy, hundreds of digital health services are available in English, and some have even been translated into Spanish. However, most of that technology is written in English. MiSalud is building a system that's culturally appropriate and inclusive.
Miriam Rivera, CEO, founder and General Partner at Ulu Ventures, says MiSalud is an organization that uses technology to make complete, inexpensive healthcare available to everyone. Their firm is delighted to be partnering with a diverse team, in a venture dedicated to improving health equity for Hispanics.
For the uninitiated, the investment round was inclusive of participants like Rise Capital, Lowercase Capital, and strategic investor, Entravision. Angel investors Sumit Agarwal, Belsasar Lepe, Alex Bitoun, and Isaac Saldana also contributed in the funding round.
© 2024 IntelligenceJournal.com. All Rights Reserved.